#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Burkitt's lymphoma (also called small noncleaved cell lymphoma) is a type of non-Hodgkin lymphoma, a cancer in the lymphatic system. Burkitt's lymphoma is the most common type of non-Hodgkin lymphoma in children. It often grows first in the lymph tissue of the head and neck, including the tonsils, or in the abdomen. It grows rapidly, so symptoms often progress very quickly and children can become quite sick within a few days to weeks. Today, more than 90% of children with Burkitt's lymphoma are cured of the disease.
Children with Burkitt's lymphoma are treated at Dana-Farber/Boston Children's through the Lymphoma Program in our Hematologic Malignancies Center. One of the top pediatric cancer centers worldwide, Dana-Farber/Boston Children’s combines the expertise of a premier cancer center – Dana-Farber Cancer Institute – and a world-class children’s hospital – Boston Children’s Hospital – to provide internationally-renowned care for children with cancer.
Find in-depth information on the Dana-Farber/Boston Children's website:
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”